Form 4: Inspire Medical Systems' Chief Technology Officer Sells Shares
SEC Filing
John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold 2,287 shares of common stock on March 3, 2025, at a price of $185.6 per share.
Summary
- John Rondoni, the Chief Technology Officer of Inspire Medical Systems, Inc., filed a Form 4 with the SEC.
- On March 3, 2025, Rondoni sold 2,287 shares of Inspire Medical Systems' common stock at a price of $185.6 per share.
- Following the transaction, Rondoni directly owns 15,500 shares of the company's common stock.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan established on May 23, 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an insider transaction under a pre-existing trading plan.
Industry Context
This is a routine disclosure of an insider transaction. It's common for executives to have pre-arranged trading plans (Rule 10b5-1) to sell shares over time.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, but the existence of a pre-arranged trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2024-05-23 | Date of Rule 10b5-1 trading plan |
| 2025-03-03 | Date of transaction (sale of shares) |
| 2025-03-05 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.